Compare Fiverr International Ltd (FVRR) vs Organon & Co. Common Stock (OGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fiverr International Ltd vs Organon & Co. Common Stock — how do they compare? Fiverr International Ltd trades at $8.56 (market cap $309.18M), while Organon & Co. Common Stock trades at $13.58 (market cap $3.62B). The key difference: Organon & Co. Common Stock is far larger — about 11.7× Fiverr International Ltd's market cap, and Organon & Co. Common Stock pays a 0.58% dividend while Fiverr International Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fiverr International Ltd for 62 Days and Organon & Co. Common Stock for 0 Days on average.
| FVRR | OGN | |
|---|---|---|
Market Cap | $309.18M | $3.62B |
Volume | 481,205 | 2,892,999 |
Sector | Media | Health |
52-Week High | $23.60 | $13.81 |
52-Week Low | $8.47 | $5.70 |
Typical Hold Time | 62 Days | 0 Days |
Enterprise Value | $61.56M | $11.04B |
Dividend Yield | — | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Fiverr International (FVRR) trades at $8.55, down 0.81% with bearish technical signals despite attractive valuation metrics including a P/E of 10.62 and P/S of 0.75. Recent Q2 2026 earnings missed expectations with revenue declining 10% year-over-year as AI disruption pressures freelance demand. The company maintains strong gross margins of 82% but faces headwinds from accelerating AI adoption compressing lower-value freelance work.
While valuation appears compelling with consensus price target of $10.50 representing 23% upside, near-term risks from AI disruption and recent earnings misses warrant caution. Analyst sentiment leans neutral with 76% hold ratings, reflecting uncertainty around growth trajectory amid structural industry shifts. Cash flow trends show volatility with negative net cash flow projected for 2026.
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Fiverr International Ltd
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.
Read more on FVRR →About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →
